ENTBF (Entheon Biomedical) Total Liabilities: $0.04 Mil (As of Feb. 2026)


What is Entheon Biomedical Total Liabilities?

Entheon Biomedical ENTBF Total Liabilities is $0.04 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Entheon Biomedical's Total Liabilities for the quarter that ended in Feb. 2026 was $0.04 Mil.

Entheon Biomedical's quarterly Total Liabilities increased from Aug. 2025 ($0.01 Mil) to Nov. 2025 ($0.02 Mil) and increased from Nov. 2025 ($0.02 Mil) to Feb. 2026 ($0.04 Mil).

Entheon Biomedical's annual Total Liabilities declined from Nov. 2023 ($0.06 Mil) to Nov. 2024 ($0.03 Mil) and declined from Nov. 2024 ($0.03 Mil) to Nov. 2025 ($0.02 Mil).

Entheon Biomedical Total Liabilities Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Total Liabilities Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 0.74 0.12 0.06 0.03 0.02

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.01 0.01 0.02 0.04

Entheon Biomedical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Entheon Biomedical's Total Liabilities for the fiscal year that ended in Nov. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.021+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.02

Total Liabilities=Total Assets (A: Nov. 2025 )-Total Equity (A: Nov. 2025 )
=0.252-0.231
=0.02

Entheon Biomedical's Total Liabilities for the quarter that ended in Feb. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.044+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.04

Total Liabilities=Total Assets (Q: Feb. 2026 )-Total Equity (Q: Feb. 2026 )
=0.208-0.164
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.04 Mil mean?
Entheon Biomedical (ENTBF) has a Total Liabilities of $0.04 Mil as of Feb. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Entheon Biomedical and its competitors.
Is Entheon Biomedical's Total Liabilities too high?
Entheon Biomedical's current Total Liabilities is $0.04 Mil.
How does Entheon Biomedical's Total Liabilities compare to VRTX and REGN?
Entheon Biomedical's Total Liabilities of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Entheon Biomedical and its competitors. Entheon Biomedical's current Total Liabilities is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Total Liabilities of $0.04 Mil. The current Total Liabilities is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Total Liabilities is $0.04 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.